Human P2Y<sub>6</sub> Receptor:  Molecular Modeling Leads to the Rational Design of a Novel Agonist Based on a Unique Conformational Preference

Stefano Costanzi, Bhalchandra V. Joshi, Savitri Maddileti, Liaman Mamedova, María J. González‐Moa, Víctor E. Márquez, T. Kendall Harden, Kenneth A. Jacobson

Journal of Medicinal Chemistry · 2005 · 72 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Combining molecular dynamics (MD) in a hydrated phospholipid (DOPC) bilayer, a Monte Carlo search, and synthesis of locked nucleotide analogues, we discovered that the Southern conformation of the ribose is preferred for ligand recognition by the P2Y(6) receptor. 2'-Deoxy-(S)-methanocarbaUDP was found to be a full agonist of the receptor and displayed a 10-fold higher potency than that for the corresponding flexible 2'-deoxyUDP. MD results also suggested a conformational change of the second extracellular loop consequent to agonist binding.

References

16